USPTO serial 79231513
A AMYLON
Reviewed by CopyMark Law Group
Reg. 5688240Status 709
- Filing date
- Status date
- Registration date
- Mar 5, 2019
- Examiner
- CIANCI, RYAN MICHAEL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with A AMYLON?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
NL-2333 CK Leiden, NL
NL-2333 CK Leiden, NL
NL-2333 CK Leiden, NL
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jess M. Collen
JESS M. COLLEN JESS M. COLLEN80 SOUTH HIGHLAND AVENUECOLLEN IPOSSINING, NY 10562Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals for treating brain conditions; pharmaceutical compositions for treating brain conditions; pharmaceutical drugs for treating brain conditions; chemico-pharmaceutical preparations for treating brain conditions; sanitary preparations for medical purposes | SECTION 71 - CANCELLED | — |
| 036 | Business fundraising for others; financial investment information; financial investment research; capital investment; venture capital funding services for inventors; venture capital funding services to emerging and start-up companies | SECTION 71 - CANCELLED | — |
| 042 | Laboratory research services relating to pharmaceuticals; medical research; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development in the field of biotechnology; biological research; clinical research in the field of biology and brain conditions; biomedical research services; pharmaceutical research services; research of pharmaceuticals; pharmaceutical products development; testing of pharmaceuticals; pharmaceutical drug development services; research and development of new products for the pharmaceutical industry; consultancy relating to pharmaceutical research and development; consultancy in the field of pharmaceutical research; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Amylon Therapeutics BV
- Other trademarks owned by Amylon Therapeutics BV
- Other trademarks owned by Amylon Therapeutics BV
- Other trademarks in Class 005
- Other trademarks in Class 036
- Other trademarks in Class 042
- Similar marks named A AMYLON
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 19, 2026 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Dec 2, 2025 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Nov 22, 2025 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Nov 21, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 21, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 19, 2025 | C71T | CANCELLED SECTION 71 | — |
| Mar 5, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jul 12, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 26, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 26, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 5, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 5, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 18, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 18, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 15, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 28, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 28, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 28, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 10, 2018 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 9, 2018 | ALIE | ASSIGNED TO LIE | — |
| Oct 26, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 26, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 26, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 26, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 26, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 17, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 16, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 16, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 25, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 25, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 30, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 14, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 14, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 9, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 8, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 7, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| May 15, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 11, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 10, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |